Evidence map›Paper›PMID 41087557›Full record

ArticleNature chemistry2025

Selective CO

Iñigo J Vitórica-Yrezábal, Craig A McAnally, Matthew P Snelgrove, Mark R Warren, Adrian H Hill, Stephen P Thompson, Martin Quinn, Sam Mottley, Stephen Mottley, Ashleigh J Fletcher and 1 more

Abstract read
In one paragraph

Article in Nature chemistry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Solid-state molecular organometallic chemistry (SMOM): a user guide toDalton transactions (Cambridge, England : 2003) · 2026
    Review
  4. CONature chemistry · 2025
    Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Iñigo J Vitórica-YrezábalDepartment of Chemistry, University of Sheffield, Sheffield, UK. inigo.vitorica@rigaku.com.ORCID http://orcid.org/0000-0001-8806-150X
Craig A McAnallyDepartment of Chemical and Process Engineering, University of Strathclyde, Glasgow, UK.ORCID http://orcid.org/0009-0007-7444-6311
Matthew P SnelgroveDepartment of Chemical and Process Engineering, University of Strathclyde, Glasgow, UK.ORCID http://orcid.org/0000-0003-2665-9084
Mark R WarrenDiamond Light Source, Harwell Science and Innovation Campus, Didcot, UK.ORCID http://orcid.org/0000-0003-1326-0744
Adrian H HillThe European Synchrotron Radiation Facility, Grenoble, France.ORCID http://orcid.org/0000-0003-1760-2967
Stephen P ThompsonDiamond Light Source, Harwell Science and Innovation Campus, Didcot, UK.ORCID http://orcid.org/0000-0001-9627-2606
Martin QuinnSchool of Natural Science, University of Manchester, Manchester, UK.
Sam MottleySchool of Natural Science, University of Manchester, Manchester, UK.
Stephen MottleySchool of Natural Science, University of Manchester, Manchester, UK.
Ashleigh J FletcherDepartment of Chemical and Process Engineering, University of Strathclyde, Glasgow, UK.ORCID http://orcid.org/0000-0003-3915-8887
Lee BrammerDepartment of Chemistry, University of Sheffield, Sheffield, UK. lee.brammer@sheffield.ac.uk.ORCID http://orcid.org/0000-0001-6435-7197

Funding

RCUK | Engineering and Physical Sciences Research Council (EPSRC) EP/F02195X/1RCUK | Engineering and Physical Sciences Research Council (EPSRC) EP/L505080/1
6 · The paper itself

Abstract

Separation of CO

Identifiers

PMID41087557
PMCPMC12580317

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.